title: Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease.
authors.affiliation: Institute of Infectious Diseases and Tropical Medicine, University of Milan, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Gori
authors.forename: M C
authors.initials: MC
authors.lastname: Rossi
authors.forename: G
authors.initials: G
authors.lastname: Marchetti
authors.forename: D
authors.initials: D
authors.lastname: Trabattoni
authors.forename: C
authors.initials: C
authors.lastname: Molteni
authors.forename: M
authors.initials: M
authors.lastname: Cogliati
authors.forename: A
authors.initials: A
authors.lastname: Bandera
authors.forename: M
authors.initials: M
authors.lastname: Clerici
authors.forename: F
authors.initials: F
authors.lastname: Franzetti
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D016207:Cytokines / Q000096:biosynthesis* / Q000187:drug effects; D005260:Female; D018023:HIV Seronegativity / Q000276:immunology*; D006679:HIV Seropositivity / Q000150:complications / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013792:Thalidomide / Q000627:therapeutic use*; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy*; D019562:Viral Load
chemical_list: D000995:Antitubercular Agents; D016207:Cytokines; D013792:Thalidomide